FilingIndex
← The Wire
TCMDNasdaq

TACTILE SYSTEMS TECHNOLOGY INC

Surgical & Medical Instruments & Apparatus · MN · CIK 1027838

Develops and provides innovative medical devices for treating underserved chronic diseases at home

$593M
Market cap
$30.27
Last close
-0.0%
1D
+15.4%
5D
246K
Volume
Price · last 39 sessions+35.0%
May 4L $22.43 · H $30.28Jun 29
185
Total filings
May 7, 2026
Last filing
12/31
Fiscal year end
8-KBylaw Amendment · Shareholder VoteMay 7, 202610-Q10-QMay 4, 20268-KResults of OperationsMay 4, 2026DEFA14ADEFA14AMar 25, 2026DEF 14ADEF 14AMar 25, 20268-KExecutive Change · Reg FD DisclosureMar 9, 202610-K10-KFeb 17, 20268-KResults of Operations · Reg FD DisclosureFeb 17, 202610-Q10-QNov 3, 20258-KResults of Operations · Company UpdateNov 3, 202510-Q10-QAug 4, 20258-KResults of OperationsAug 4, 20258-KExecutive Change · Shareholder VoteMay 9, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEFA14ADEFA14AMar 28, 2025DEF 14ADEF 14AMar 28, 202510-K10-KFeb 18, 20258-KResults of OperationsFeb 18, 20258-KExecutive Change · Reg FD DisclosureJan 13, 2025SC 13GSC 13GNov 13, 2024SC 13GMS INITIALNov 8, 202410-Q10-QNov 4, 20248-KResults of Operations · Company UpdateNov 4, 202410-Q10-QAug 5, 20248-KResults of OperationsAug 5, 20248-KReg FD Disclosure · Company UpdateJul 5, 20248-KBylaw Amendment · Shareholder VoteMay 9, 202410-Q10-QMay 6, 20248-KResults of OperationsMay 6, 2024DEFA14ADEFA14AApr 23, 20248-KExecutive Change · Results of OperationsApr 23, 2024DEFA14ADEFA14AMar 27, 2024DEF 14ADEF 14AMar 27, 202410-K10-KFeb 20, 20248-KResults of OperationsFeb 20, 2024SC 13GAMENDMENT TO FORM 13GFeb 14, 2024SC 13GSC 13GFeb 14, 202410-Q10-QNov 6, 20238-KResults of OperationsNov 6, 2023SC 13GSCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIPNov 6, 20238-KExecutive Change · Reg FD DisclosureOct 2, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 2023SC 13GSC 13GJul 28, 20238-KExecutive Change · Reg FD DisclosureJul 18, 20238-KShareholder VoteMay 9, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AMar 27, 2023DEF 14ADEF 14AMar 27, 20238-KExecutive Change · Reg FD DisclosureMar 14, 20238-KMaterial Agreement · Company UpdateFeb 28, 2023424B5424B5Feb 27, 2023424B5424B5Feb 23, 202310-K10-KFeb 21, 20238-KResults of OperationsFeb 21, 2023SC 13GSC 13GFeb 6, 20238-KExecutive Change · Reg FD DisclosureJan 5, 20238-KBylaw AmendmentDec 23, 20228-KReg FD DisclosureNov 29, 202210-Q10-QNov 7, 20228-KResults of OperationsNov 7, 202210-Q10-QAug 1, 20228-KResults of OperationsAug 1, 2022SC 13GSC 13GJul 8, 2022SC 13GSC 13GJun 23, 2022SC 13GSCHEDULE 13GMay 27, 20228-KShareholder VoteMay 10, 202210-Q10-QMay 2, 20228-KResults of OperationsMay 2, 2022DEFA14ADEFA14AMar 28, 2022DEF 14ADEF 14AMar 28, 202210-K10-KFeb 23, 20228-KResults of OperationsFeb 22, 20228-KReg FD DisclosureFeb 22, 2022SC 13GSC 13GFeb 11, 2022SC 13GMS INITIALFeb 9, 2022SC 13GSC 13GJan 26, 20228-KExecutive Change · Reg FD DisclosureJan 5, 2022

Insider Activity

In the 90 days to Feb 24, 2026: 3 sold $1.6M.

DateInsiderActionSharesPriceValue
Feb 24, 2026Dodd Sheri LouiseChief Executive OfficerSell10,993$28.94$318K
Feb 24, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSell7,701$28.94$223K
Feb 24, 2026Burns KristieSr. VP Mktg & Clinical AffairsSell6,246$28.94$181K
Feb 23, 2026Dodd Sheri LouiseChief Executive OfficerSell14,703$28.28$416K
Feb 23, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSell5,322$28.28$151K
Feb 23, 2026Burns KristieSr. VP Mktg & Clinical AffairsSell4,279$28.28$121K
Feb 23, 2026Dodd Sheri LouiseChief Executive OfficerSell537$28.69$15K
Feb 23, 2026Birkemeyer Elaine M.CHIEF FINANCIAL OFFICERSell196$28.69$6K
Feb 23, 2026Burns KristieSr. VP Mktg & Clinical AffairsSell160$28.69$5K
Jan 2, 2026Burns KristieSr. VP Mktg & Clinical AffairsSell5,139$28.85$148K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance